Tolga Atilla Ceranoglu, MD

Biography

Tolga Atilla Ceranoglu, MD, received his medical degree from Marmara University School of Medicine, in Istanbul, Turkey. He then completed his psychiatry training at Brockton VA Medical Center and child psychiatry at Massachusetts General Hospital. He currently serves as Director of Psychiatry Service at Shriners Hospitals for Children, Boston and is staffed at MGH Bressler Program for Autism and Pediatric Psychopharmacology.

Dr. Ceranoglu’s research focuses on novel treatments of Autism Spectrum Disorders across the life span. His current treatment study focuses on use of near infrared LED light to improve core features associated with ASD, including social cognition and executive function deficits.

Dr. Ceranoglu also focuses on psychiatric disorders and long term outcomes among children who experienced severe burn injuries. Dr. Ceranoglu is a member of the Media Committee of American Academy of Child and Adolescent Psychiatry and regularly presents at national meetings on the psychological effects of media use among individuals with Autism Spectrum Disorders.

BRAIN Funded Projects

Evaluation of Transcranial Photobiomodulation in Autism: Double-Blind, Placebo-Controlled, Randomized Study

Evaluating efficacy and safety of t-PBM treatment of autism and provide the first step towards FDA approval.

Recent & Selected Publications

Ceranoglu TA, Cassano P, Hoskova B, et al. Transcranial Photobiomodulation in Adults with High-Functioning Autism Spectrum Disorder: Positive Findings from a Proof-of-Concept Study. Photobiomodul Photomed Laser Surg. 2022;40(1):4-12. doi:10.1089/photob.2020.4986. Read abstract

Ceranoglu TA, Wozniak J, Fried R, et al. A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum Disorder. J Child Adolesc Psychopharmacol. 2019;29(1):28-33. doi:10.1089/cap.2018.0021

BRAIN Synchrony Symposia presentations